Abstract
Alteplase has been shown to be effective in preventing central venous access clotting in patients on hemodialysis. Because of a high phosphorus content in its excipient, it can inadvertently contaminate blood samples, leading the physician in care of the patient to erroneously increase dialysis time or change diet in order to control the pseudo-hyperphosphatemia.
Similar content being viewed by others
References
Dunea G, Domenico L, Gunnerson P, Winston-Willis F (1991) A survey of permanent double lumen catheters in hemodialysis patients. ASAIO Trans 37:M276–277
Daeihagh P, Jordan P, Chen J, Rocco M (2000) Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 36:75–79
Gittins M, Coulthard MG, Matthews JNS (2005) Alteplase v Heparin locks to maintain central line patency in hemodialysis lines. Arch Dis Child 90 [Suppl 11]:A30
Schenk P, Rosenkranz AR, Wolfl G, Horl WH, Traindl O (2000) Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Am J Kidney Dis 35:130–136
McBryde KD, Wilcox J, Kher KK (2005) Hyperphosphatemia due to fosphenytoin in a pediatric ESRD patient. Pediatr Nephrol 20:1182–1185
Rowe RC, Sheskey PJ, Weller PJ (2003) Handbook of pharmaceutical excipients, 4th edn. Pharmaceutical Press, London, pp 442–443
Ball CL, Tobler K, Ross BC, Connors MR, Lyon ME (2004) Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter. Clin Chem Lab Med 42:107–108
Cohen AM, Magazanik A, van-der Lijn E, Shaked P, Levinsky H (1994) Pseudohyperphosphatemia incidence in an automatic analyzer. Eur J Clin Chem Clin Biochem 32:559–561
Mandry JM, Posner MR, Tucci JR, Eil C (1991) Hyperphosphatemia in multiple myeloma due to a phosphate binding immunoglobulin. Cancer 68:1092–1094
Lelhey DJ, Daugirdas JT, Ing TS, Reid RW (1985) Spurious hyperphosphatemia due to hyperlipidemia. Arch Int Med 145:743–744
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cachat, F., Bardy, D., Durussel, C. et al. Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter. Pediatr Nephrol 21, 301–302 (2006). https://doi.org/10.1007/s00467-005-2088-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-2088-1